Sumner R

School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, 85 Park Road, Grafton, Auckland 1023, New Zealand. Electronic address: r.sumner@auckland.ac.nz.

1 preprint · 8 papers · ORCID

PreprintKetamine

Neurite Complexity and Plasticity Markers Track Synaptic Vesicle Density in the Living Human Brain: A Multimodal PET-MRI-EEG Study

Agnorelli C, Peill J, Kurtin DL +25

Europe PMC2026
ArticleLSD

LSD microdosing for major depressive disorder: Mood and pharmacokinetic outcomes from a Phase 2a trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +11

Europe PMC2026
ArticleLSD

LSD microdosing in major depressive disorder: results from an open-label trial.

Daldegan-Bueno D, Donegan CJ, Sumner R +12

Europe PMC2026
ArticleLSD

A Novel Stability Indicating High Performance Liquid Chromatography Method for Lysergic Acid Diethylamide Quantification: From Microdosing Applications to Broader Analytical Use.

Bansal M, Miller E, Sumner R +3

Europe PMC2025
ArticleLSD

Qualitative content analysis of expectations in participants with depression about to begin LSD microdosing treatment: Identifying the need for psychedelic expectancy measures.

Donegan CJ, Daldegan-Bueno D, Noorani T +9

Europe PMC2025
ArticleLSD

LSD increases sleep duration the night after microdosing.

Allen N, Jeremiah A, Murphy R +8

Europe PMC2024
ArticleLSD

An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1).

Donegan CJ, Daldegan-Bueno D, Sumner R +15

Europe PMC2023
ArticlePsychedelics

Psychedelics and neural plasticity.

Sumner R, Lukasiewicz K

Europe PMC2023
ArticleLSD

Acute Mood-Elevating Properties of Microdosed Lysergic Acid Diethylamide in Healthy Volunteers: A Home-Administered Randomized Controlled Trial.

Murphy RJ, Sumner R, Evans W +10

Europe PMC2023